SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-042525
Filing Date
2023-08-14
Accepted
2023-08-14 17:04:38
Documents
69
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grph-20230630.htm   iXBRL 10-Q 2627579
2 EX-31.1 grph-ex31_1.htm EX-31.1 20960
3 EX-32.1 grph-ex32_1.htm EX-32.1 11997
  Complete submission text file 0000950170-23-042525.txt   10376427

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20230630.xsd EX-101.SCH 65955
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20230630_pre.xml EX-101.PRE 379885
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grph-20230630_cal.xml EX-101.CAL 43392
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grph-20230630_def.xml EX-101.DEF 229289
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20230630_lab.xml EX-101.LAB 523160
63 EXTRACTED XBRL INSTANCE DOCUMENT grph-20230630_htm.xml XML 2173198
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 231171792
SIC: 2836 Biological Products, (No Diagnostic Substances)